Trials / Terminated
TerminatedNCT01488968
Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
A Phase II Randomized Control Trial of Conventional Versus Hypofractionated Radiation Regimen in Single Phase Using IMRT Technique and Long Term Androgen Suppression Therapy in High-risk Prostate Cancer Patients.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hypofractionated regimen in high-risk prostate cancer will allow the investigators to deliver higher biological doses to targets in order to improve tumor control and with acceptable rectal toxicity compared to conventional fractionation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Standard Radiation Treatment | 39 radiation treatments |
| RADIATION | Hypofractionated radiation treatment | 25 radiation treatments |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2018-10-15
- Completion
- 2018-10-15
- First posted
- 2011-12-09
- Last updated
- 2025-06-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01488968. Inclusion in this directory is not an endorsement.